New Strategies for Treatment of ALK Rearranged Non-Small Cell Lung Cancers

Por Sasaki, Takaaki, Jänne, Pasi A.
Publicado em 2011

Successful alectinib treatment after crizotinib‐induced interstitial lung disease

Por Fujiuchi, Satoru, Fujita, Yuka, Sasaki, Takaaki, Ohsaki, Yoshinobu
Publicado no Respirol Case Rep (2016)

Interstitial lung disease associated with human papillomavirus vaccination

Por Yamamoto, Yasushi, Kazebayashi, Yoshihiro, Hirai, Noriko, Sasaki, Takaaki, Ohsaki, Yoshinobu
Publicado no Respir Med Case Rep (2015)

The Biology and Treatment of EML4-ALK Non-Small Cell Lung Cancer

Por Sasaki, Takaaki, Rodig, Scott J., Chirieac, Lucian R., Jänne, Pasi A.
Publicado em 2010

Histamine H(1) antagonist levocetirizine as a potential cause of lung injury

Por Endo, Satoshi, Yamamoto, Yasushi, Minami, Yoshinori, Okumura, Shunsuke, Sasaki, Takaaki, Ohsaki, Yoshinobu
Publicado no Respirol Case Rep (2015)

Feasibility of adjuvant chemotherapy with S-1 consisting of a 4-week administration and a two-week rest period in patients with completely resected non-small cell lung cancer

Por OKUMURA, SHUNSUKE, SASAKI, TAKAAKI, SATOH, KAZUHIRO, KITADA, MASAHIRO, NAGASE, ATSUSHI, YATSUYANAGI, EIJI, OHSAKI, YOSHINOBU
Publicado em 2013

An Amino-indazole Scaffold with Spectrum Selective Kinase Inhibition of FLT3, PDGFRα and Kit

Por Deng, Xianming, Zhou, Wenjun, Weisberg, Ellen, Wang, Jinhua, Zhang, Jianming, Sasaki, Takaaki, Nelson, Erik, Griffin, James D., Jänne, Pasi A., Gray, Nathanael S.
Publicado em 2012

Discovery of 3,5-Diamino-1,2,4-triazole Ureas as Potent Anaplastic Lymphoma Kinase Inhibitors

Por Deng, Xianming, Wang, Jinhua, Zhang, Jianming, Sim, Taebo, Kim, Nam Doo, Sasaki, Takaaki, Luther, William, George, Rani E., Jänne, Pasi A., Gray, Nathanael S.
Publicado em 2011

Evaluation of a Quantitative Serological Assay for Diagnosing Chronic Pulmonary Aspergillosis

Por Fujiuchi, Satoru, Fujita, Yuka, Suzuki, Hokuto, Doushita, Kazushi, Kuroda, Hikaru, Takahashi, Masaaki, Yamazaki, Yasuhiro, Tsuji, Tadakatsu, Fujikane, Toshiaki, Osanai, Shinobu, Sasaki, Takaaki, Ohsaki, Yoshinobu
Publicado no J Clin Microbiol (2016)

The neuroblastoma associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK translocated cancers

Por Sasaki, Takaaki, Okuda, Katsuhiro, Zheng, Wei, Butrynski, James, Capelletti, Marzia, Wang, Liping, Gray, Nathanael S., Wilner, Keith, Christensen, James G., Demetri, George, Shapiro, Geoffrey I., Rodig, Scott J., Eck, Michael J., Jänne, Pasi A.
Publicado em 2010

Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion Oncogene

Por Chen, Zhao, Sasaki, Takaaki, Tan, Xiaohong, Carretero, Julian, Shimamura, Takeshi, Li, Danan, Xu, Chunxiao, Wang, Yuchuan, Adelmant, Guillaume O., Capelletti, Marzia, Lee, Hyun Joo, Rodig, Scott J., Borgman, Christa, Park, Seung-il, Kim, Hyeong Ryul, Padera, Robert, Marto, Jarrod A., Gray, Nathanael S., Kung, Andrew L., Shapiro, Geoffrey I., Jänne, Pasi A., Wong, Kwok-Kin
Publicado em 2010

A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors

Por Sasaki, Takaaki, Koivunen, Jussi, Ogino, Atsuko, Yanagita, Masahiko, Nikiforow, Sarah, Zheng, Wei, Lathan, Christopher, Marcoux, J. Paul, Du, Jinyan, Okuda, Katsuhiro, Capelletti, Marzia, Shimamura, Takeshi, Ercan, Dalia, Stumpfova, Magda, Xiao, Yun, Weremowicz, Stanislawa, Butaney, Mohit, Heon, Stephanie, Wilner, Keith, Christensen, James G., Eck, Michel J., Wong, Kwok-Kin, Lindeman, Neal, Gray, Nathanael S., Rodig, Scott J., Jänne, Pasi A.
Publicado em 2011